Garden State Investment Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$487K Buy
7,059
+3,167
+81% +$219K 0.12% 144
2025
Q1
$274K Buy
3,892
+273
+8% +$19.2K 0.09% 193
2024
Q4
$312K Buy
3,619
+1,476
+69% +$127K 0.09% 171
2024
Q3
$255K Sell
2,143
-130
-6% -$15.5K 0.08% 189
2024
Q2
$325K Sell
2,273
-179
-7% -$25.6K 0.11% 158
2024
Q1
$314K Buy
2,452
+383
+19% +$49K 0.11% 166
2023
Q4
$214K Buy
+2,069
New +$214K 0.09% 186